Build a university at Babri mosque site, says AAP leader

Agencies
December 5, 2018

New Delhi, Dec 5: Delhi Deputy Chief Minister Manish Sisodia has said a university should come up at the site of the disputed Babri Masjid-Ram Janmabhoomi site in Ayodhya in Uttar Pradesh. He emphasised that ‘Ram Rajya’ can be ushered through education and not by constructing a grand temple.

“My stand is that with a consensus from both sides (Hindus and Muslims), let’s build a good university at that place,” Sisodia said in an interview with NDTV that was aired on Sunday. “Hindu, Muslim, Christian, Indian, foreigner — students from all communities may attend that university and from there should spring Lord Ram’s ideals. Ram Rajya would come if we teach our children and not by building a mandir,” Sisodia said when asked what was the Aam Aadmi Party’s (AAP) stand on Ram Mandir debate.

Asked about the current wave of caste politics in Indian politics, Sisodia, who is also Delhi’s Education Minister, said that the only way to end it was through education. “When I was at Japan University, the people there were talking about a new concept of running cars with hydrogen and on the same day on Twitter we were debating about Lord Hanuman’s caste. It is really unfortunate but the only way to move forward is by education,” he said.

Without taking any particular name, Sisodia slammed the political parties of spreading casteism at university levels “by appointing Vice Chancellors subscribing to Hindutva who try to impose it on the students”. “On one hand, you talk about ‘Digital India’ but your actions resemble that of Vijay Mallya,” Sisodia said.

Talking about the Lok Sabha elections due next year, Sisodia said the AAP government would be focusing on all the seven Lok Sabha seats in Delhi. “We will also keep our focus on Punjab and Haryana for the 2019 elections,” he said.

When asked whether Delhi Police should be with the state government, Sisodia remarked that even if his government plans to take an action, it never gets implemented on the ground level because of different governments controlling different authorities in Delhi. “Delhi Police need to be under the Delhi government,” he said. He also said the previous Sheila Dikshit-led government “didn’t do any work” in Delhi. “If her government had done anything, we wouldn’t have to struggle like this to get work done,” he said.

Comments

Mute spectator
 - 
Thursday, 6 Dec 2018

Dear Fairman,

 

Please don't convert an unfair activity of demolishing Babri Masjid as fair.  It is a cowardly act of safeguarding democracy.  Tomorrow another praying place will be demolished in the guise of similar reason and you keep on constructing hospitals?

 

 

 

FAIRMAN
 - 
Wednesday, 5 Dec 2018

Well said,

Very Very Well said, as the same was suggested by many in the past.

 

Such a contraversials  definitely devide the nation. Animity can spike without bounds and borders.

 

-  Yesterday there was Masjid.

- Today someone destroying it telling Baber had destroyed the Masjid and built temple.

- Tomorrow when Muslims become stronger, they might distroy the Mandir and build Masjid.

 

Our future children will die, suffer. We dont want to repeat again as what haened;

The God does not want to spill the blood for Masjid or Mandir.

 

Let us make our future generation live in peace than today we do.

 

God bless India.

 

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 16,2020

New Delhi, Jul 16: With the highest single-day spike of 32,695 cases and 606 deaths reported in the last 24 hours, India's COVID-19 tally on Thursday reached 9,68,876, informed the Union Ministry of Health and Family Welfare on Thursday.

The total number of COVID-19 cases includes 3,31,146 active cases, 6,12,815 cured/discharged/migrated and 24,915 deaths.

As per the Ministry, Maharashtra -- the worst-affected state from the infection -- has a total of 2,75,640 COVID-19 cases and 10,928 fatalities. While Tamil Nadu has a tally of 1,51,820 cases and 2,167 deaths due to COVID-19.

Delhi has reported a total of 1,16,993 cases and 3,487 deaths due to COVID-19.

Meanwhile, as per the information provided by the Indian Council of Medical Research (ICMR), 1,27,39,490 samples have been tested for COVID-19 till 15th July, of these 3,26,826 samples were tested yesterday.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 21,2020

New Delhi, June 21: India today recorded the highest single-day spike in infections so far with 15,413 new cases reported in the last 24 hours. The total number of positive cases in India touched 4.11 lakh on Sunday.

As per the Ministry of Health data, the total number of coronavirus cases stands at 4,10,461 cases which include 1,69,451 active cases, 2,27,756 recovered/migrated cases, and 13,254 deaths as per the Ministry of Health data.

With 1,28,205 confirmed cases of COVID-19 so far, Maharashtra remains the worst-affected state in the country, followed by Tamil Nadu with 56,845 and Delhi 56,746. 

Delhi reported its highest single-day increase of 3,630 new coronavirus cases. With this, the state’s tally rose to 56,746. The toll rose to 2,112 with 77 deaths. As many as 7,725 people recovered, taking the total recoveries to 31,294.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.